hrp0084p2-409 | GH & IGF | ESPE2015

The Influence of GH Therapy on Chemerin Concentration, Body Mass and Selected Parameters of Carbohydrate Metabolism in Prepubertal Non-Obese Children with GH Deficiency

Rudzka-Kocjan Agnieszka , Szalecki Mieczyslaw

Background: Chemerin is an adipocytokine which plays a great role in metabolism of carbohydrates. Chemerin concentration correlates positively with body mass (BM). GH deficiency (GHD) is associated with excess of abdominal fat tissue also in patients with normal BMI.Objective and hypotheses: To estimate the chemerin concentration and its correlation with BM and carbohydrate metabolism in non-obese, prepubertal children with isolated GHD before (GHD untre...

hrp0084p2-411 | GH & IGF | ESPE2015

Estimation of Adipsin, Omentin and Vaspin Concentration in Prepubertal Children with GH Deficiency before and after 6 Months of GH Treatment

Rudzka-Kocjan Agnieszka , Szalecki Mieczyslaw

Background: GH deficiency (GHD) is usually associated with excess of abdominal fat tissue and increased risk of developing cardiovascular diseases. Adipose tissue produces different adipocytokines that could explain the relationship between excess of fat tissue and increased metabolic risk. Adipsin, omentin and vaspin are adipocytokines which are still not well examined.Objective and hypotheses: To estimate the effect of 6 months GH therapy on serum conc...

hrp0086p2-p651 | Growth P2 | ESPE2016

Estimation of FGF21 Concentration in Prepubertal Children with Growth Hormone Deficiency before and after 6 Months of Growth Hormone Treatment

Rudzka-Kocjan Agnieszka , Szalecki Mieczyslaw , Malinowska Anna

Background: Fibroblast growth factor 21 (FGF21) is a metabolic and growth regulator. The growth-promoting effect of GH in children with GH deficiency (GHD) depends on many factors. FGF21 concentration in and its interaction with growth deficiency and growth response to GH therapy in GHD was not examined.Objective and hypotheses: To estimate the FGF21 concentration and its correlation with degree of growth deficiency and growth response in non-obese, prep...

hrp0086p2-p766 | Pituitary and Neuroendocrinology P2 | ESPE2016

Congenital Craniopharyngioma: Report of Two Cases

Bogusz Agnieszka , Moszczynska Elzbieta , Szalecki Mieczyslaw

Introduction: Craniopharyngiomas are slow growing epithelial tumors located in the sellar or suprasellar region of the brain. Adamantinomatous subtype affects mainly children and accounts for 5–10% of all intracranial paediatric tumors. Diagnosed antenatal and neonatal craniopharyngiomas are very seldom, about 40 such cases have been detected to date. They are characterised by large size, progressive hydrocephalus and a poor prognosis.Aim: The aim o...

hrp0084p3-973 | GH & IGF | ESPE2015

A Patient with an 13q Deletion Syndrome, Important Growth Delay and Somatotropine Insufficiency Undergoing Growth Hormone Therapy–Case Report.

Wolaniecka-Deahan Kinga , Szalecki Mieczyslaw , Chrzanowska Krystyna

Background: Growth deficiency is a common symptom of many genetic syndromes. 13q deletion is a very rare genetic syndrome described in almost 200 cases. Growth reduction is a constant symptom along with mental retardation, congenital defects varying according to the deleted region of chromosome 13.Objective and hypotheses: The aim of this paper was to present the case of a 12 year old patient with an interstitial deletion 13q (22.3–31.1), important ...

hrp0084p3-1125 | Pituitary | ESPE2015

Combined Pituitary Hormone Deficiency

Kot Karolina , Moszczynska Elzbieta , Szalecki Mieczyslaw

Background: Combined pituitary hormone deficiency (CPHD) may be congenital or acquired disorder, which affects more than one hormonal axis. Congenital hipopituitarism includes heterogenic group of disturbances. It may be result of mutations or deletions in genes for signaling and transcription factors responsible for pituitary development. The disorder might affect one or multiple family members. The age of appearance and intensity of the first hormone deficiency symptoms may ...

hrp0086p1-p742 | Pituitary and Neuroendocrinology P1 | ESPE2016

Precocious Puberty in Septo-Optic Dysplasia Syndrome – Presentation of 2 Cases

Malinowska Anna , Marczak Elzbieta , Rudzka-Kocjan Agnieszka , Szalecki Mieczyslaw

Background: Septo-optic dysplasia (SOD) is a rare, congenital condition that mostly occurs sporadically, but can also be caused by mutations in HESX1, OTX2, SOX2, SOX3 genes. Symptoms of SOD include: optic nerve hypoplasia, hypopituitarism and midline brain abnormalities such as absence of septum pellucidum and/or corpus callosum. Hypopituitarism in SOD usually manifests as growth hormone deficiency followed by central hypothyroidism as well as deficiency of gonadotropines. Pr...

hrp0086p1-p746 | Pituitary and Neuroendocrinology P1 | ESPE2016

Prognostic Significance of the Proliferative Index Ki67 for Patients with Craniopharyngiomas

Moszczynska Elzbieta , Bogusz Agnieszka , Szymanska Sylwia , Grajkowska Wieslawa , Szalecki Mieczyslaw

Background: Craniopharyngioma is a benign, slow-growing epithelial tumor, in children it contributes to 5–10% of all brain tumors. Its incidence is 0.5-2 per 1,000,000 person-years. 30–50% of these tumors are recognized in childhood, most often in ages 5–14, no sex predilection is observed. It is located mainly in the sellar/parasellar region, in children adamantinomatous variant, with tendency to recur, is the most common type. Views on the usefulness of immuno...

hrp0082p2-d1-318 | Diabetes | ESPE2014

Serum Level of Osteoprotegerin and Total sRANKL in Adolescents with Type 1 Diabetes Mellitus

Szalecki Mieczyslaw , Wierzbicka Elzbieta , Pludowski Pawel , Jaworski Maciej

Background: There is still small clinical data regarding the influence of IDDM on bone structure, density and biochemical markers of bone turnover.Objective and hypotheses: To evaluate the potential role of OPG/sRANKL system in adolescents with IDDM and the influence of age, sex, metabolic control, diabetes duration and age of onset.Method: Serum concentration of OPG and total sRANKL in 60 children (25 boys and 33 girls) with IDDM ...

hrp0084p3-815 | Endocrine Oncology | ESPE2015

Craniopharyngioma – Symptoms, Treatment and Follow Up – An Analysis of 100 Cases

Moszczynska Elzbieta , Bogusz Agnieszka , Bendysz-Golatowska Anna , Szalecki Mieczyslaw

Background: Craniopharyngiomas are rare embryogenic malformations of the sellar area with low-grade histological malignancy. Its incidence is 0.5–2.0 cases per million persons per year, 30–50% of all cases become apparent in children.Objective and hypotheses: The aim of the study was to analyse the clinical symptoms and treatment efficacy in children diagnosed with Craniopharyngioma.Method: A retrospective analysis includ...